Search

Novo Nordisk A-S

Затворен

СекторЗдравеопазване

43.24 0.12

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

43.12

Максимум

43.53

Ключови измерители

By Trading Economics

Приходи

-28B

21B

Продажби

-18B

78B

P/E

Средно за сектора

10.624

56.432

EPS

0.96

Дивидентна доходност

4.13

Марж на печалбата

26.742

Служители

66,700

EBITDA

-31B

39B

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+1.76% upside

Дивиденти

By Acuity

Дивидентна доходност

Средно за сектора

4.13%

2.27%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-16B

192B

Предишно отваряне

43.12

Предишно затваряне

43.24

Настроения в новините

By Acuity

62%

38%

270 / 339 Класиране в Healthcare

Novo Nordisk A-S Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.09.2026 г., 23:41 ч. UTC

News

Iovance Biotherapeutics granted inducement stock options for 179.75k shares to new employees, contributing to a modest decline in after-market hours.

18.09.2026 г., 23:31 ч. UTC

News

BlackRock Inc. shares are modestly lower in after-market trading amid heightened legal concerns as the DOJ considers intervention in an antitrust lawsuit against the company.

18.09.2026 г., 23:26 ч. UTC

News

State Street Corp declines in after-market trading as the U.S. Department of Justice considers intervention in a state antitrust lawsuit regarding energy price inflation.

18.09.2026 г., 23:16 ч. UTC

News

Union Pacific Corp's stock is trading higher in after-market hours following UBS's upgrade to Buy and a price target increase to $339, citing expected cargo growth.

18.09.2026 г., 23:11 ч. UTC

News

AutoNation Inc has been downgraded from Buy to Hold amid industry challenges, yet the stock is rising in after-market trading as the broader market advances.

18.09.2026 г., 23:11 ч. UTC

News

Leidos Holdings Inc. has secured an $85 million contract from the U.S. Department of War for aerospace systems design, with shares rising in after-market trading.

18.09.2026 г., 23:06 ч. UTC

News

AbbVie Inc. is experiencing a slight decline in after-market trading, positioned near the lower end of its recent trading range despite promising myeloma study results.

18.09.2026 г., 23:06 ч. UTC

News

Boeing is in talks with NASA to expand its Starliner program, potentially adding ten or more flights, as the stock moves higher in after-hours trading.

18.09.2026 г., 23:06 ч. UTC

News

Chevron Corp has declined in after-market trading, despite Goldman Sachs raising its price target to $240 and Piper Sandler setting an even higher target of $243.

18.09.2026 г., 23:06 ч. UTC

News

Okta Inc appointed Helen Riley to its board, enhancing leadership as shares rise in after-market trading, aligning with a broader market advance.

18.09.2026 г., 23:06 ч. UTC

News
Social Media

Nike shares are advancing in after-market hours despite recent challenges, including a significant decline and hitting a 12-year low.

18.09.2026 г., 23:06 ч. UTC

News

General Motors Co is advancing in after-market trading following its decision to reinstate Apple’s CarPlay and Android Auto in its vehicles.

18.09.2026 г., 23:06 ч. UTC

News

Medtronic PLC raised its fiscal 2027 profit forecast and reported first-quarter revenue of $9.756 billion, exceeding expectations, in after-market trading.

18.09.2026 г., 23:06 ч. UTC

News

RTX Corp's backlog hit a record $289 billion, with the stock advancing in after-market trading, despite remaining below its 20-day moving average.

18.09.2026 г., 23:06 ч. UTC

News

Celsius Holdings Inc shares are higher in after-market trading, continuing a positive trend despite ongoing legal scrutiny over its Alani Nu product line.

18.09.2026 г., 23:01 ч. UTC

News
Social Media

Northrop Grumman targets $10 billion in annual international sales by 2031, while shares trade lower in after-market hours.

18.09.2026 г., 23:01 ч. UTC

News

Kimberly-Clark Corp plans to divest assets related to its $40 billion Kenvue acquisition to address EU antitrust concerns, with shares modestly higher in after-market trading.

18.09.2026 г., 23:01 ч. UTC

Social Media
News

Accenture PLC announced a $1 billion partnership with Anthropic to enhance AI evaluation capabilities, leading to a sharp advance in shares during after-market hours.

18.09.2026 г., 23:01 ч. UTC

News

Bitcoin is sharply higher, trading well above its previous close amid a rally in the cryptocurrency market, driven by strong investor sentiment and recent Fed announcements.

18.09.2026 г., 23:01 ч. UTC

News

Ethereum is advancing sharply, continuing its upward trajectory alongside a broader cryptocurrency rally, despite earlier pulling back from a session high.

18.09.2026 г., 23:01 ч. UTC

News

Ethereum is advancing sharply, remaining significantly higher since Thursday's close, as the cryptocurrency market rallies alongside Bitcoin surpassing $81k.

18.09.2026 г., 23:01 ч. UTC

News

Sharply higher amid strong investor sentiment and Fed announcements.

18.09.2026 г., 23:01 ч. UTC

News
Social Media

Wendy's Co shares are trading modestly higher in after-market hours despite concerns over Meritage Hospitality Group's Chapter 11 bankruptcy filing affecting 314 locations.

18.09.2026 г., 22:51 ч. UTC

News

Lockheed Martin Corp receives an $871.2 million contract modification for F-35 support, contributing to a modest after-market hours gain.

18.09.2026 г., 22:51 ч. UTC

News

Hf Foods Group Inc. has terminated its $100 million at-the-market equity offering program, leading to a sharp decline in after-market trading.

18.09.2026 г., 22:01 ч. UTC

News

Simply Good Foods Co is facing a securities fraud class action lawsuit, contributing to a modest decline in after-market trading following concerns over OWYN's sales performance.

18.09.2026 г., 21:41 ч. UTC

News

Amneal Pharmaceuticals received FDA approval for its lanreotide injection, launching the product immediately, driving shares higher in after-market hours.

18.09.2026 г., 21:03 ч. UTC

Macro News
News
Macro Event

The Bank of Japan raised its key interest rate to 1.25%, boosting the USD/JPY pair, which is trading higher above Thursday's close.

18.09.2026 г., 21:01 ч. UTC

News

Navient Corp is seeing a modest increase in after-market trading, reflecting routine performance and placing the price around the middle of its one-month range.

18.09.2026 г., 21:01 ч. UTC

News
Macro Event
Correlated Moves

The Bank of Japan raised its key short-term interest rate to 1.25%, causing GBP/JPY to trade modestly higher, though still below its 20-day moving average.

Сравнение с други в отрасъла

Ценова промяна

Novo Nordisk A-S Прогноза

Ценова цел

By TipRanks

1.76% нагоре

12-месечна прогноза

Среден 44 USD  1.76%

Висок 47 USD

Нисък 40 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Novo Nordisk A-S през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

6 ratings

0

Купи

5

Задържане

1

Продай

Настроение

By Acuity

270 / 339 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Novo Nordisk A-S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.